AA
ZYME icon

ALPS Advisors’s Zymeworks ZYME Stock Holding History

ALPS Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,277
Closed -$266K – 1150
2024
Q2 		$266K Sell
31,277
-163
-0.5% -$1.45K ﹤0.01% 894
2024
Q1 		$331K Buy
+31,440
New +$349K ﹤0.01% 881
2021
Q4 		– Sell
-56,851
Closed -$1.65M – 988
2021
Q3 		$1.65M Sell
56,851
-3,562
-6% -$118K 0.02% 337
2021
Q2 		$2.1M Sell
60,413
-22,714
-27% -$721K 0.02% 323
2021
Q1 		$2.63M Buy
83,127
+657
+0.8% +$26.7K 0.03% 232
2020
Q4 		$3.9M Buy
82,470
+24,289
+42% +$1.13M 0.04% 191
2020
Q3 		$2.71M Sell
58,181
-3,939
-6% -$135K 0.04% 196
2020
Q2 		$2.24M Sell
62,120
-18,440
-23% -$679K 0.03% 227
2020
Q1 		$2.86M Buy
80,560
+1,303
+2% +$53.3K 0.04% 186
2019
Q4 		$3.6M Buy
+79,257
New +$2.88M 0.03% 185

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ALPS Advisors's ZYME Position: Q3 2024 in Review

ALPS Advisors sold out of Zymeworks (ZYME) in Q3 2024, closing a stake of 31,277 shares — an estimated $266K sold.

ALPS Advisors first reported a position in ZYME in Q4 2019 and held it in 10 quarters. The position peaked at $3.9M in Q4 2020. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.

  • ALPS Advisors reported no remaining Zymeworks position as of Q3 2024 after selling out during the quarter.
  • ALPS Advisors sold 31,277 Zymeworks shares in Q3 2024, an estimated $266K.
  • ALPS Advisors first reported a position in Zymeworks in Q4 2019 and held it in 10 quarters.
  • ALPS Advisors's Zymeworks position peaked at $3.9M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.